Galera Therapeutics Inc. (GRTX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Galera Therapeutics Inc.

    OTC: GRTX · Real-Time Price · USD
    0.03
    0.00 (9.09%)
    At close: Apr 04, 2025, 2:24 PM

    Galera Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -18.96M -59.08M -62.22M -80.53M
    Depreciation & Amortization
    		 20K 259K 114K 778K
    Stock-Based Compensation
    		 2.54M 5.56M 7.16M 7.23M
    Other Working Capital
    		 n/a -721K 1.48M -2.53M
    Other Non-Cash Items
    		 n/a 11.34M 11.57M 7.19M
    Deferred Income Tax
    		 -203K n/a -70K n/a
    Change in Working Capital
    		 n/a -2.93M 17K -2.63M
    Operating Cash Flow
    		 n/a -44.85M -43.43M -67.96M
    Capital Expenditures
    		 n/a -59K -25K -283K
    Cash Acquisitions
    		 n/a n/a -24.02K -5.52K
    Purchase of Investments
    		 n/a -22.64M -59.89M -71.98M
    Sales Maturities Of Investments
    		 n/a 49.99M 83.91M 77.5M
    Other Investing Acitivies
    		 -46K n/a 24.02K 5.52K
    Investing Cash Flow
    		 -46K 27.29M 23.99M 5.24M
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 2.22M 2.2M 81K 58.77M
    Financial Cash Flow
    		 2.22M 31.5M 3.89M 66.71M
    Net Cash Flow
    		 -9.97M 13.94M -15.54M 3.99M
    Free Cash Flow
    		 n/a -44.91M -43.45M -68.24M

    Add to Watchlist